Clinical Trials Update: July 13, 2006

Addictions AsthmaPsoriasis and Psoriatic Disorders

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Addictions

The purpose of this study is to learn more about the strength and effects of prescription opioids.

Candidates for this trial must be able to make several visits over a period of about seven weeks. If you currently use prescription opiates and are interested in participating in a research study, please call the Center for Human Behavioral Sciences -- 859-257-4581 -- for a confidential interview to see if you qualify. You will be paid for your participation.

The research site is in Lexington, Ky.

More information

Please see http://www.centerwatch.com/patient/studies/cat219.html.

-----

Asthma

Clinical Research Associates is conducting a clinical research trial of an investigational medication for patients with asthma.

Participants for this trial must be between the ages of 12 and 75 with moderate-to-severe asthma and currently using the high-dose inhaled corticosteroids and long-acting beta-agonists.

The research site is located in Oklahoma City, Okla.

More information

Please see http://www.centerwatch.com/patient/studies/cat16.html.

-----

Psoriasis and Psoriatic Disorders

People with plaque psoriasis who are planning on using Enbrel for treatment are asked to participate in a research study being conducted by New York University School of Medicine.

Candidates 18 or older who are planning on using Enbrel to treat their plaque psoriasis and have not been prescribed Enbrel previously may qualify.

The research site is in New York City.

More information

Please see http://www.centerwatch.com/patient/studies/cat126.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com